Authors

• Irina Bancos (ORCID: https://orcid.org/0000-0001-9332-2524)
• Vanessa Fell (ORCID: https://orcid.org/0000-0003-4583-8694)
• Elizabeth J. Atkinson (ORCID: https://orcid.org/0000-0002-1191-3775)
• Sara J. Achenbach
• Bahar Bahrani Fard (ORCID: https://orcid.org/0000-0003-2652-5481)
• Rashi Sandooja (ORCID: https://orcid.org/0000-0003-0927-3884)
• Jasmine Saini (ORCID: https://orcid.org/0000-0001-7156-6229)
• Malavika Suresh
• Yana Hleibiehova
• Bahaa Salama
• Elio Ferreira Taveras

Institutions

• Nebraska Medical Center (US)
• Yale New Haven Hospital (US)
• Mayo Clinic (US)
• Banner Wyoming Medical Center (US)
• Mayo Clinic in Arizona (US)
• Mayo Clinic in Florida (US)
• University of Nebraska Medical Center (US)

Publication Details

Journal

Journal of the Endocrine Society

Published

2025-09-03

DOI

https://doi.org/10.1210/jendso/bvaf145

Primary Topic

Tryptophan and brain disorders

Type

article

Field-Weighted Citation Impact

0.00

Funders

• AstraZeneca
• Recordati Rare Diseases
• National Institutes of Health
• National Institute of Diabetes and Digestive and Kidney Diseases